[HTML][HTML] Quantification of amyloid PET for future clinical use: a state-of-the-art review

HG Pemberton, LE Collij, F Heeman, A Bollack… - European journal of …, 2022 - Springer
Amyloid-β (Aβ) pathology is one of the earliest detectable brain changes in Alzheimer's
disease (AD) pathogenesis. The overall load and spatial distribution of brain Aβ can be …

[HTML][HTML] Technical and clinical validation of commercial automated volumetric MRI tools for dementia diagnosis—a systematic review

HG Pemberton, LAM Zaki, O Goodkin, RK Das… - Neuroradiology, 2021 - Springer
Developments in neuroradiological MRI analysis offer promise in enhancing objectivity and
consistency in dementia diagnosis through the use of quantitative volumetric reporting tools …

FDA-approved machine learning algorithms in neuroradiology: a systematic review of the current evidence for approval

AG Yearley, CMW Goedmakers, A Panahi… - Artificial Intelligence in …, 2023 - Elsevier
Over the past decade, machine learning (ML) and artificial intelligence (AI) have become
increasingly prevalent in the medical field. In the United States, the Food and Drug …

Incorporation of quantitative MRI in a model to predict temporal lobe epilepsy surgery outcome

M Morita-Sherman, M Li, B Joseph… - Brain …, 2021 - academic.oup.com
Quantitative volumetric brain MRI measurement is important in research applications, but
translating it into patient care is challenging. We explore the incorporation of clinical …

Interpretable deep learning‐based hippocampal sclerosis classification

D Kim, J Lee, J Moon, T Moon - Epilepsia Open, 2022 - Wiley Online Library
Objective To evaluate the performance of a deep learning model for hippocampal sclerosis
classification on the clinical dataset and suggest plausible visual interpretation for the model …

Trends in clinical validation and usage of US Food and Drug Administration-cleared artificial intelligence algorithms for medical imaging

M Khunte, A Chae, R Wang, R Jain, Y Sun, JR Sollee… - Clinical radiology, 2023 - Elsevier
AIM To examine the current landscape of US Food and Drug Administration (FDA)-approved
artificial intelligence (AI) medical imaging devices and identify trends in clinical validation …

Imaging aspects of the hippocampus

IS Alves, AMN Coutinho, APF Vieira, BP Rocha… - Radiographics, 2022 - pubs.rsna.org
The hippocampus is one of the most sophisticated structures in the brain, owing to its
complex anatomy, intriguing functions, relationship with other structures, and relevant …

[HTML][HTML] Diagnostic performance of MRI volumetry in epilepsy patients with hippocampal sclerosis supported through a random forest automatic classification …

JP Princich, PA Donnelly-Kehoe, A Deleglise… - Frontiers in …, 2021 - frontiersin.org
Introduction: Several methods offer free volumetry services for MR data that adequately
quantify volume differences in the hippocampus and its subregions. These methods are …

Artificial intelligence in epilepsy—applications and pathways to the clinic

A Lucas, A Revell, KA Davis - Nature Reviews Neurology, 2024 - nature.com
Artificial intelligence (AI) is rapidly transforming health care, and its applications in epilepsy
have increased exponentially over the past decade. Integration of AI into epilepsy …

[HTML][HTML] Epilepsy in Pediatric Patients—Evaluation of Brain Structures' Volume Using VolBrain Software

MM Woźniak, M Zbroja, M Matuszek… - Journal of Clinical …, 2022 - mdpi.com
Epilepsy is one of the most frequent serious brain disorders. Approximately 30,000 of the
150,000 children and adolescents who experience unprovoked seizures are diagnosed with …